The National Academy of Medicine has named an international committee to assess how COVID-19 vaccine development and other policies could facilitate global efforts to prepare for seasonal flu and a flu pandemic.

As part of the initiative, the Department of Health and Human Services has asked the National Academies of Sciences, Engineering, and Medicine to release consensus reports this fall on vaccine research and development; vaccine distribution and supply chains; public health interventions and countermeasures; and global coordination, partnerships and financing.

NAM will host a public workshop this spring to hear from experts and gather feedback to inform the reports.

Related News Articles

News
The Food and Drug Administration today revoked the emergency use authorization that allowed for the investigational monoclonal antibody therapy bamlanivimab,…
Headline
Drug overdose deaths in the United States rose by an estimated 29% between September 2019 and September 2020 to 90,237, according to preliminary data …
Headline
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices is holding an emergency meeting this afternoon on the Johnson…
Headline
The Food and Drug Administration today urged health care facilities to transition away from using crisis capacity conservation strategies, such as…
Headline
The Food and Drug Administration today authorized for emergency use the first prescription antibody test that allows individuals to collect a finger-stick…
Headline
The Food and Drug Administration this week authorized several SARS-CoV-2 serial screening tests for asymptomatic individuals. They include two over-the-counter…